Topical rivastigmine, a selective acetylcholinesterase inhibitor, lowers intraocular pressure in rabbits

Journal of Ocular Pharmacology and Therapeutics

Volumn 16, Issue 1, 2000, Pages 29-35

  Goldblum, David ^a   Garweg, Justus G ^a   Böhnke, Matthias ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; RIVASTIGMINE;

ANIMAL EXPERIMENT; CHOLINESTERASE INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; NONHUMAN; RABBIT;

EID: 0033979520     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2000.16.29     Document Type: Conference Paper

References (20)

1. Kronfeld, P.C. Eserine and pilocarpine: Our 100 year old allies. Surv. Ophthalmol. 14:479-485, 1970.
2. De Roetth, A. Jr. Lens opacities in glaucoma patients on phospholine iodide therapy. Am. J. Ophthalmol. 62:619-628, 1966.
3. Hiscox, P.E.A. and McCulloch, C. The effect of echothiophate iodide on systemic cholinesterase. Can. J. Ophthalmol. 1:274-282, 1966.
4. Polinsky, R.J. Clinical pharmacology of rivastigmine: A new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Clin. Ther. 20:634-647, 1998.
5. Enz, A. and Floersheim, P. Cholinesterase inhibitors: An overview of their mechanisms of action. In Alzheimer disease: From molecular biology to therapy, Becker, R. and Giacobini, E. eds., Birkhäuser, Boston, 1996, pp. 211-215.
6. Siek, G.C., Katz, L.S., Fishman, E.B., Korosi, T.S., and Marquis, J.K. Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain. Biol. Psychiatry 27:573-580, 1990.
7. Massoulié, J. and Bon, S. The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. Ann. Rev. Neurosci. 5:57-106, 1982.
8. Lachmann, C. and Wilson, I.B. Multiple forms of acetylcholinesterase from the ciliary body of the human eye. Exp. Eye Res. 19:195-199, 1974.
9. Bar-Ilan, A. and Beilin, M. Diurnal variations in intraocular pressure in the albino rabbit: Relationship to morning intraocular pressure. Ophthalmic Res. 29:110-116, 1997.
10. Leopold, I.H. and Furman, M. Cholinesterase isoenzymes in human ocular tissue homogenates. Am. J. Ophthalmol. 72:460-463, 1971.
11. Furman, M., Lazar, M., and Irving, L.H. Cholinesterase isoenzymes in rabbit ocular tissue homogenates. Doc. Ophthalmol 26:185-191, 1969.
12. Harris, L.S., Mittag, T.W., and Shimmyo, M. Properties of cholinesterases of human ocular tissues. Ophthalmologica 165:153-160, 1972.
13. Abrams, L.S., Vitale, S., and Jampel, H.D. Comparison of three tonometers for measuring intraocular pressure in rabbits. Invest. Ophthalmol. Vis. Sci. 37:940-944, 1996.
14. Kaufmann, P.L. and Barany, E.H. Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgous monkey. Invest. Ophthalmol. 15:793-807, 1976.
15. Berggren, L. Effect of parasympathomimetic and sympathomimetic drugs on secretion in vitro by the ciliary processes of the rabbit eye. Invest. Ophthalmol. 4:91-97, 1965.
16. Gaasterland, D., Kupfer, C., and Ross, K. Studies of aqueous humor dynamics in man: IV. Effects of pilocarpine upon measurements in young normal volunteers. Invest. Ophthalmol. 14:848-853, 1975.
17. Jonas, J.B., Schnidt, A.M., Müller-Bergh, J.A., Schlötzer-Schrehardt, U.M., and Naumann, G.O.H. Human optic nerve fiber count and optic disc size. Invest. Ophthalmol. Vis. Sci. 33:2012-2018, 1992.
18. Vickers, J.C. The cellular mechanism underlying neuronal degeneration in glaucoma: Parallels with Alzheimer's disease. Aust. NZ J. Ophthalmol. 25:105-109, 1997.
19. Tsai, C.S., Ritch, R., Schwartz, B., Lee, S.S., Miller, N.R., Chi, T., and Hsieh, F.Y. Optic nerve head and nerve fiber layer in Alzheimer's disease. Arch. Ophthalmol. 109:199-204, 1991.
20. Chen, Y., Shohami, E., Constantini, S., and Weinstock, M. Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse. J. Neurotrauma 15:231-237, 1998.